Carregant...
Erlotinib in the Treatment of Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single Arm Phase II Clinical Trial
BACKGROUND: Cutaneous squamous cell carcinoma (CSCC) is a very common malignancy. Most patients present with localized disease. Recurrent and metastatic disease is rare, and there is no standard therapy for these patients. These tumors frequently overexpress the epidermal growth factor receptor (EGF...
Guardat en:
| Publicat a: | Cancer |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935588/ https://ncbi.nlm.nih.gov/pubmed/29579331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31346 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|